Core A (Administrative Core), led by the Program's Director, Paul M. Hassoun, MD, and Co-Director,Rubin M. Tuder, will provide essential administrative and secretarial support and ensure overall directionand organization of the entire Program. In addition, this Core will provide accounting support that willensure appropriate fiscal and scientific oversight, monitoring and compliance with federal and institutionalgrant management regulations, the latter through several formal mechanisms. The objectives of theAdministrative core are (i) centralization of all administrative actions and financial recording keeping, (ii) toassist with statistical and data processing support for the projects (iii)to prepare scientific and financialreports as required by the university and the NHLBI, (iv) to ensure that the SCCOR research meets thehighest standards through periodic review by the internal and external review panels, (v) to facilitate theuse of common resources, (vi)to foster exchange of scientific information and ideas, and (viii) provide theprojects and cores with a review of all expenditures on a monthly basis and deal with UniversityAccounting and Grants offices concerning grant budgets. Core A will coordinate the inter-project, andinter-departmental, collaborative arrangements and evolve new arrangements as deemed necessary forthe scientific progress of the SCCOR project as a whole. Core personnel will orchestrate monthlymeetings of the project leaders that will be held to discuss scientific and administrative matters. Core Awill organize regular research seminars on Thursday mornings which will allow SCCOR investigators topresent their work in progress to other researchers. Coordinated administrative services will ensureoptimal purchasing practices, facilitate communications, and promote scientific interaction.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
1P50HL084946-01
Application #
7394285
Study Section
Special Emphasis Panel (ZHL1-CSR-S (M1))
Project Start
2007-01-12
Project End
2011-12-31
Budget Start
2007-01-12
Budget End
2007-12-31
Support Year
1
Fiscal Year
2007
Total Cost
$118,221
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Hsu, Steven; Kokkonen-Simon, Kristen M; Kirk, Jonathan A et al. (2018) Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension. Circulation 137:2360-2370
Mercurio, Valentina; Mukherjee, Monica; Tedford, Ryan J et al. (2018) Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 197:388-391
Mecoli, Christopher A; Shah, Ami A; Boin, Francesco et al. (2018) Vascular complications in systemic sclerosis: a prospective cohort study. Clin Rheumatol 37:2429-2437
Yu, Bing; Pulit, Sara L; Hwang, Shih-Jen et al. (2016) Rare Exome Sequence Variants in CLCN6 Reduce Blood Pressure Levels and Hypertension Risk. Circ Cardiovasc Genet 9:64-70
Gao, Li; Emond, Mary J; Louie, Tin et al. (2016) Identification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing. Arthritis Rheumatol 68:191-200
Hassoun, Paul M; Zamanian, Roham T; Damico, Rachel et al. (2015) Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 192:1102-10
Ohyama, Yoshiaki; Ambale-Venkatesh, Bharath; Chamera, Elzbieta et al. (2015) Comparison of strain measurement from multimodality tissue tracking with strain-encoding MRI and harmonic phase MRI in pulmonary hypertension. Int J Cardiol 182:342-348
Auer, Paul L; Nalls, Mike; Meschia, James F et al. (2015) Rare and Coding Region Genetic Variants Associated With Risk of Ischemic Stroke: The NHLBI Exome Sequence Project. JAMA Neurol 72:781-8
Parker, Sarah J; Raedschelders, Koen; Van Eyk, Jennifer E (2015) Emerging proteomic technologies for elucidating context-dependent cellular signaling events: A big challenge of tiny proportions. Proteomics 15:1486-502
Damico, Rachel; Kolb, Todd M; Valera, Lidenys et al. (2015) Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension. Am J Respir Crit Care Med 191:208-18

Showing the most recent 10 out of 108 publications